Mimedx Group Files 8-K on Financials
Ticker: MDXG · Form: 8-K · Filed: Oct 30, 2024 · CIK: 1376339
| Field | Detail |
|---|---|
| Company | Mimedx Group, Inc. (MDXG) |
| Form Type | 8-K |
| Filed Date | Oct 30, 2024 |
| Risk Level | low |
| Pages | 4 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
TL;DR
MIMEDX filed an 8-K today covering financials and operations.
AI Summary
Mimedx Group, Inc. filed an 8-K on October 30, 2024, reporting on its results of operations and financial condition. The filing also includes Regulation FD disclosures and financial statements and exhibits. The company is incorporated in Florida and headquartered in Marietta, GA.
Why It Matters
This 8-K filing provides crucial updates on Mimedx Group's financial performance and operational status, which can influence investor decisions.
Risk Assessment
Risk Level: low — This is a routine 8-K filing for financial reporting and does not indicate any immediate or significant risks.
Key Players & Entities
- MIMEDX GROUP, INC. (company) — Registrant
- October 30, 2024 (date) — Date of earliest event reported
- Marietta, GA (location) — Principal executive offices location
- Florida (location) — State of incorporation
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on the Results of Operations and Financial Condition of Mimedx Group, Inc., along with Regulation FD Disclosures and Financial Statements and Exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on October 30, 2024.
Where is Mimedx Group, Inc. headquartered?
Mimedx Group, Inc.'s principal executive offices are located at 1775 West Oak Commons Ct., NE, Marietta, GA 30062.
In which state is Mimedx Group, Inc. incorporated?
Mimedx Group, Inc. is incorporated in Florida.
What is the SIC code for Mimedx Group, Inc.?
The Standard Industrial Classification (SIC) code for Mimedx Group, Inc. is 3841, which corresponds to Surgical & Medical Instruments & Apparatus.
Filing Stats: 1,107 words · 4 min read · ~4 pages · Grade level 12.2 · Accepted 2024-10-30 16:56:00
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 par value per share MDXG The Nasdaq
Filing Documents
- d117946d8k.htm (8-K) — 31KB
- d117946dex991.htm (EX-99.1) — 227KB
- d117946dex992.htm (EX-99.2) — 14KB
- d117946dex993.htm (EX-99.3) — 17KB
- g117946ex99_2p10g1.jpg (GRAPHIC) — 182KB
- g117946ex99_2p11g1.jpg (GRAPHIC) — 230KB
- g117946ex99_2p12g1.jpg (GRAPHIC) — 211KB
- g117946ex99_2p13g1.jpg (GRAPHIC) — 243KB
- g117946ex99_2p14g1.jpg (GRAPHIC) — 389KB
- g117946ex99_2p15g1.jpg (GRAPHIC) — 297KB
- g117946ex99_2p16g1.jpg (GRAPHIC) — 327KB
- g117946ex99_2p1g1.jpg (GRAPHIC) — 344KB
- g117946ex99_2p2g1.jpg (GRAPHIC) — 365KB
- g117946ex99_2p3g1.jpg (GRAPHIC) — 434KB
- g117946ex99_2p4g1.jpg (GRAPHIC) — 212KB
- g117946ex99_2p5g1.jpg (GRAPHIC) — 304KB
- g117946ex99_2p6g1.jpg (GRAPHIC) — 393KB
- g117946ex99_2p7g1.jpg (GRAPHIC) — 193KB
- g117946ex99_2p8g1.jpg (GRAPHIC) — 202KB
- g117946ex99_2p9g1.jpg (GRAPHIC) — 183KB
- g117946ex99_3p10g1.jpg (GRAPHIC) — 373KB
- g117946ex99_3p11g1.jpg (GRAPHIC) — 368KB
- g117946ex99_3p12g1.jpg (GRAPHIC) — 286KB
- g117946ex99_3p13g1.jpg (GRAPHIC) — 295KB
- g117946ex99_3p14g1.jpg (GRAPHIC) — 330KB
- g117946ex99_3p15g1.jpg (GRAPHIC) — 152KB
- g117946ex99_3p1g1.jpg (GRAPHIC) — 305KB
- g117946ex99_3p2g1.jpg (GRAPHIC) — 365KB
- g117946ex99_3p3g1.jpg (GRAPHIC) — 426KB
- g117946ex99_3p4g1.jpg (GRAPHIC) — 379KB
- g117946ex99_3p5g1.jpg (GRAPHIC) — 461KB
- g117946ex99_3p6g1.jpg (GRAPHIC) — 437KB
- g117946ex99_3p7g1.jpg (GRAPHIC) — 365KB
- g117946ex99_3p8g1.jpg (GRAPHIC) — 323KB
- g117946ex99_3p9g1.jpg (GRAPHIC) — 327KB
- 0001193125-24-247640.txt ( ) — 13811KB
- mdxg-20241030.xsd (EX-101.SCH) — 3KB
- mdxg-20241030_lab.xml (EX-101.LAB) — 18KB
- mdxg-20241030_pre.xml (EX-101.PRE) — 11KB
- d117946d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description of Exhibit 99.1 Earnings Press Release dated October 30, 2024. 99.2 Earnings Call Presentation, dated October 30, 2024. 99.3 Investor Presentation, dated October 30, 2024. 104 The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Exchange Act, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MIMEDX GROUP, INC. Date: October 30, 2024 By: /s/ Doug Rice Doug Rice Chief Financial Officer